Data edition of
Residue An evidence-graded reference for peptide science

Sermorelin clinical trials

Every study registered on ClinicalTrials.gov that lists Sermorelin as an intervention, as of the data edition — what is being tested, in whom, by whom, and how far it has got.

Registered studies
27
Active or recruiting
1
Completed
21
With posted results
11
Planned or actual enrollment
2,107participants, summed
Registered studies of Sermorelin by phase and status
PhaseStudiesBreakdown
Phase 1 5
5 completed, 0 active or recruiting, 0 stopped, 0 other
Phase 2 7
4 completed, 1 active or recruiting, 2 stopped, 0 other
Phase 3 4
3 completed, 0 active or recruiting, 0 stopped, 1 other
Phase 4 1
0 completed, 0 active or recruiting, 1 stopped, 0 other
Not applicable 8
7 completed, 0 active or recruiting, 1 stopped, 0 other
Observational 2
2 completed, 0 active or recruiting, 0 stopped, 0 other
Figure 1. 27 studies on ClinicalTrials.gov match the registry search sermorelin. Multi-phase studies are counted at their highest phase. Open the full trial feed

Conditions studied

  1. Growth Hormone Deficiency7
  2. Abdominal Obesity3
  3. Aging3
  4. HIV Infections2
  5. Lipodystrophy2
  6. HIV Lipodystrophy2
  7. Mild Cognitive Impairment2
  8. HIV2
  9. Healthy Volunteers1
  10. HIV-1-infection1
  11. Frailty1
  12. Impaired Physical Function1

Lead sponsors

  1. Massachusetts General Hospital8
  2. Theratechnologies3
  3. University of Pennsylvania2
  4. University of Washington2
  5. Cairo University1
  6. Children's Mercy Hospital Kansas City1
  7. National Center for Research Resources (NCRR)1
  8. Merck KGaA, Darmstadt, Germany1

The registry, study by study

Registration is not evidence of benefit; many registered studies never publish. Status and dates are as reported by sponsors to ClinicalTrials.gov.

Status
Phase

27 shown

Registered studies of Sermorelin
StudyPhaseStatusStartnSponsor
NCT06554717Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV Phase 2 Recruiting Jul 2025 100 Massachusetts General Hospital
NCT03375788Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular RiskResults posted Phase 2 Completed Jan 2019 51 Massachusetts General Hospital
NCT02553603The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment Phase 1 Completed Jul 2017 22 The University of Texas Medical Branch, Galveston
NCT03031535Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers Phase 1 Completed Jan 2017 32 Dauntless Pharmaceuticals
NCT02736591Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response Phase 3 Unknown status Jun 2016 210 Cairo University
NCT02196831Tesamorelin Effects on Liver Fat and Histology in HIVResults posted N/A Completed Jul 2015 61 Massachusetts General Hospital
NCT02271282Estradiol-Receptor Blockade in Older Men and Women Phase 1 Completed Dec 2014 40 Mayo Clinic
NCT02507245Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD) Observational Completed Jan 2014 48 Stefania La Grutta, MD
NCT01632592Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue N/A Withdrawn Jan 2014 0 Massachusetts General Hospital
NCT01410799Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the ElderlyResults posted Phase 2 Terminated May 2011 13 University of Pennsylvania
NCT01359488VRS-317 in Adult Subjects With Growth Hormone Deficiency Phase 1 Completed Mar 2011 50 Versartis Inc.
NCT01263717Effects of Growth Hormone Releasing Hormone in HIVResults posted N/A Completed Dec 2010 54 Massachusetts General Hospital
NCT00850564Effect of Short Term Growth Hormone Releasing Hormone in Healthy MenResults posted N/A Completed Feb 2009 15 Massachusetts General Hospital
NCT00795210Effects of Short-term Growth Hormone in HIV-infected PatientsResults posted N/A Completed Feb 2009 25 Massachusetts General Hospital
NCT00675506Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are ObeseResults posted Phase 2 Completed Jul 2008 60 Massachusetts General Hospital
NCT02012556Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients Phase 1 Completed May 2008 18 Theratechnologies
NCT00807365Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the ElderlyResults posted Phase 2 Terminated Dec 2007 5 Johns Hopkins University
NCT00608023TH9507 Extension Study in Patients With HIV-Associated LipodystrophyResults posted Phase 3 Completed Aug 2007 263 Theratechnologies
NCT00324064Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing N/A Completed Jul 2007 90 Children's Mercy Hospital Kansas City
NCT00720902Adult Growth Hormone Deficiency and Cardiovascular RiskResults posted Phase 4 Terminated Feb 2007 7 Columbia University
NCT00257712SMART: Somatotrophics, Memory, and Aging Research Trial Phase 2 Completed Feb 2006 151 University of Washington
NCT00123253TH9507 in Patients With HIV-Associated Lipodystrophy Phase 3 Completed Jun 2005 412 Theratechnologies
NCT00791843The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart FailureResults posted Phase 2 Completed Mar 2004 3 University of Pennsylvania
NCT01060488Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency Phase 3 Completed Jan 2004 69 Merck KGaA, Darmstadt, Germany
NCT03018886Diagnosing Adult Growth Hormone Deficiency N/A Completed May 2001 160 Helsinki University Central Hospital
NCT00000380Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances N/A Completed Jun 1996 — University of Washington
NCT00004332Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly Observational Completed May 1993 148 National Center for Research Resources (NCRR)

Run this search on ClinicalTrials.gov → Query term: sermorelin